Author Archives: admin


Stem-Cell Based Bone Grafts Industry Market Size Technological Advancement And Growth Analysis With Forecast To 2025 – 3rd Watch News

A new research study has been presented by UpMarketResearch.com offering a comprehensive analysis on the Global Stem-Cell Based Bone Grafts Industry Market where user can benefit from the complete market research report with all the required useful information about this market. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact is covered in the report. The report discusses all major market aspects with expert opinion on current market status along with historic data. This market report is a detailed study on the growth, investment opportunities, market statistics, growing competition analysis, major key players, industry facts, important figures, sales, prices, revenues, gross margins, market shares, business strategies, top regions, demand, and developments.

The Stem-Cell Based Bone Grafts Industry Market report provides a detailed analysis of the global market size, regional and country-level market size, segment growth, market share, competitive landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunity analysis, strategic market growth analysis, product launches, and technological innovations.

Get a Free Sample Copy of the Stem-Cell Based Bone Grafts Industry Market Report with Latest Industry Trends @ https://www.upmarketresearch.com/home/requested_sample/90942

Major Players Covered in this Report are: company 1company 2company 3company 4company 5company 6company 7company 8company 9

Global Stem-Cell Based Bone Grafts Industry Market SegmentationThis market has been divided into Types, Applications, and Regions. The growth of each segment provides an accurate calculation and forecast of sales by Types and Applications, in terms of volume and value for the period between 2020 and 2026. This analysis can help you expand your business by targeting qualified niche markets. Market share data is available on the global and regional level. Regions covered in the report are North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America. Research analysts understand the competitive strengths and provide competitive analysis for each competitor separately.

By Types:Type 1Type 2Type 3

By Applications:Application 1Application 2Application 3

To get Incredible Discounts on this Premium Report, Click Here @ https://www.upmarketresearch.com/home/request_for_discount/90942

Global Stem-Cell Based Bone Grafts Industry Market Regions and Countries Level AnalysisRegional analysis is a highly comprehensive part of this report. This segmentation sheds light on the sales of the Stem-Cell Based Bone Grafts Industry on regional- and country-level. This data provides a detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.

The report offers an in-depth assessment of the growth and other aspects of the market in key countries including the US, Canada, Mexico, Germany, France, the UK, Russia, Italy, China, Japan, South Korea, India, Australia, Brazil, and Saudi Arabia. The competitive landscape chapter of the global market report provides key information about market players such as company overview, total revenue (financials), market potential, global presence, Stem-Cell Based Bone Grafts Industry sales and revenue generated, market share, prices, production sites and facilities, products offered, and strategies adopted. This study provides Stem-Cell Based Bone Grafts Industry sales, revenue, and market share for each player covered in this report for a period between 2016 and 2020.

Make an Inquiry of this Report @ https://www.upmarketresearch.com/home/enquiry_before_buying/90942

Why Choose Us:

Table of Contents1. Executive Summary2. Assumptions and Acronyms Used3. Research Methodology4. Market Overview5. Global Market Analysis and Forecast, by Types6. Global Market Analysis and Forecast, by Applications7. Global Market Analysis and Forecast, by Regions8. North America Market Analysis and Forecast9. Latin America Market Analysis and Forecast10. Europe Market Analysis and Forecast11. Asia Pacific Market Analysis and Forecast12. Middle East & Africa Market Analysis and Forecast13. Competition Landscape

About UpMarketResearch:Up Market Research (https://www.upmarketresearch.com) is a leading distributor of market research report with more than 800+ global clients. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Contact Info UpMarketResearchName Alex MathewsEmail [emailprotected]comOrganization UpMarketResearchAddress 500 East E Street, Ontario, CA 91764, United States.

Continued here:
Stem-Cell Based Bone Grafts Industry Market Size Technological Advancement And Growth Analysis With Forecast To 2025 - 3rd Watch News

Stem Cell Banking Market Poised to Expand at a Robust Pace Over 2020 To 2027 | Cryo-Save AG, StemCyte India Therapeutics Pvt. Ltd., Cryo-Cell…

Stem Cell Banking

Stem Cell Banking Market provides a birds eye view of the current proceeding within the Stem Cell Banking market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Stem Cell Banking market and offers a clear assessment of the projected market fluctuations during the forecast period. The different factors that are likely to impact the overall dynamics of the Stem Cell Banking market over the forecast period (2020-2027) including the current trends, growth opportunities, restraining factors, and more are discussed in detail in the market study.

Leading Players Of Stem Cell Banking Market:- Cordlife, ViaCord (A Subsidiary of PerkinElmer), Cryo-Save AG, StemCyte India Therapeutics Pvt. Ltd., Cryo-Cell International, Inc., SMART CELLS PLUS, Vita 34, LifeCell, Global Cord Blood Corporation, CBR Systems, Inc.

Get Sample PDF Of Stem Cell Banking Market @https://www.theinsightpartners.com/sample/TIPBT00002082/

Key Reasons to Purchase:

To gain insightful analyses of the Covid-19 Impact on Stem Cell Banking market and have a comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact on the global Covid-19 Impact on Stem Cell Banking market.

Learn about the Covid-19 Impact on Stem Cell Banking market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements.

Stem Cell Banking Market: Regional analysis includes:

An Overview of the Impact of COVID-19 on this Market:

The pandemic of COVID-19 continues to expand and impact over 175 countries and territories. Although the outbreak appears to have slowed in China, COVID-19 has impacted globally. The pandemic could affect three main aspects of the global economy: production, supply chain, and firms and financial markets. National governments have announced largely uncoordinated, country-specific responses to the virus. As authorities encourage social distancing and consumers stay indoors, several businesses are hit. However, coherent, coordinated, and credible policy responses are expected to offer the best chance at limiting the economic fallout.

National governments and international bodies are focused on adopting collaborative efforts to encourage financial institutions to meet the financial needs of customers and members affected by the coronavirus. However, there are some sectors that have remained unscathed from the impact of the pandemic and there are some that are hit the hardest.

Reasons to Purchase Stem Cell Banking report is:

Gives a complete understanding of the Stem Cell Banking Market to express competitor information, analysis, and insights to formulate effective RD strategies.

Collect data of the developing participants having the potentially profitable portfolio in this space and create effective counter-strategies to gain competitive benefits.

Note: Access insightful study with over 150+ pages, list of tables & figures, profiling 20+ companies.

Are you a Start-up willing to make it Big in the Business? Grab an Exclusive PDF Brochure@https://www.theinsightpartners.com/buy/TIPBT00002082/

The research study can answer the following Key questions:

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

For More Information Kindly Contact:Call: +1-646-491-9876

Email:[emailprotected]

Read more from the original source:
Stem Cell Banking Market Poised to Expand at a Robust Pace Over 2020 To 2027 | Cryo-Save AG, StemCyte India Therapeutics Pvt. Ltd., Cryo-Cell...

Small Animal Imaging Equipment Market By Covid-19 Impact Analysis Volume and Value, Revenue, Business Opportunity, Future Projections, and Key Trends…

The research study Small Animal Imaging Equipment market 2020 launched by ABRReports.com provides the detailed analysis of the current market status, investment plans, production and consumption, price trends, and analysis by the market player, by region, by type, by application and etc, and custom research can be added according to specific requirements

Get Sample Copy of the report at https://www.abrreports.com/industry-insights/covid-19-impact-on-2020-2026-global-and-regional-small-animal-imaging-equipment-industry-production-sales-and-consumption-status-and-prospects-professional-market-research-report-standard-version?form=request-report-sample

The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 50 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth.

The key players covered in the Small Animal Imaging Equipment Market research report are:By Market Players:IDEXXHeskaCarestream HealthEsaoteHallmarqAgfa HealthcareKaixin ElectricMindrayBCF TechnologySedecalChisonBruker CorporationMinXrayDiagnostic Imaging Systems

By TypeOptical ImagingRadionuclide ImagingMRIComputed Tomography ImagingUltrasound Imaging

By ApplicationCancer and Anti-cancer Drug ResearchImmunology and Stem Cell ResearchPathological Mechanism and Virus ResearchGene Expression and ProteinBiophotonic DetectionFood Supervision and Environmental Supervision

Click to access full report and Table of Content at https://www.abrreports.com/industry-insights/covid-19-impact-on-2020-2026-global-and-regional-small-animal-imaging-equipment-industry-production-sales-and-consumption-status-and-prospects-professional-market-research-report-standard-version

The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.

Key pointers of the Table of Contents:

Chapter 1 Industry OverviewChapter 2 Global Small Animal Imaging Equipment Competition by Types, Applications, and Top Regions and CountriesChapter 3 Production Market AnalysisChapter 4 Global Small Animal Imaging Equipment Sales, Consumption, Export, Import by Regions (2015-2020)Chapter 5 North America Small Animal Imaging Equipment Market AnalysisChapter 6 East Asia Small Animal Imaging Equipment Market AnalysisChapter 7 Europe Small Animal Imaging Equipment Market AnalysisChapter 8 South Asia Small Animal Imaging Equipment Market AnalysisChapter 9 Southeast Asia Small Animal Imaging Equipment Market AnalysisChapter 10 Middle East Small Animal Imaging Equipment Market AnalysisChapter 11 Africa Small Animal Imaging Equipment Market AnalysisChapter 12 Oceania Small Animal Imaging Equipment Market AnalysisChapter 13 South America Small Animal Imaging Equipment Market AnalysisChapter 14 Company Profiles and Key Figures in Small Animal Imaging Equipment BusinessChapter 15 Global Small Animal Imaging Equipment Market Forecast (2021-2026)Chapter 16 Conclusions

Purchase the research study @

https://www.abrreports.com/industry-insights/covid-19-impact-on-2020-2026-global-and-regional-small-animal-imaging-equipment-industry-production-sales-and-consumption-status-and-prospects-professional-market-research-report-standard-version/checkout?option=one

About Us:

ABR Reports (Advanced Business Research Reports) is the premium market research reselling company that offers market research reports to individuals, organizations, and industries to enhance and strengthen the decision making process. With an associate thoroughgoing list of market research Publishers, we tend to cut across all the business verticals covering 5000+ micro markets and offer market size and share analysis, industry trends, information on products, regional market, and keen business insights to our clients.

Contact Us:

Scott HarrisSales ManagerEmail ID: [emailprotected]Phone No.: +1-561-448-7424

Go here to read the rest:
Small Animal Imaging Equipment Market By Covid-19 Impact Analysis Volume and Value, Revenue, Business Opportunity, Future Projections, and Key Trends...

Global Cell Isolation Technology Market 2020 Competition Landscape and Growth Opportunity, Industry Status and Forecast 2025 – Jewish Life News

Global Cell Isolation Technology Market Growth (Status and Outlook) 2020-2025 organized by researchers atMarketsandResearch.bizpresents a detailed diagram of the market in terms of current and future trends driving the profit pattern. The report includes informative data figures and key insights regarding the market components such as market size, market share, market segmentation, significant growth drivers, and market competition. The report outlines expected business up-downs, different aspects impacting economic cycles in the market, demand, changing customer sentiments, key companies operating in the global Cell Isolation Technology market, and regional landscape with the help of statistics, diagrams, charts, and graphs. It provides a SWOT analysis of the competitive landscape of the market.

Then the report covers factors such as industry value chain, key consumption trends, recent patterns of customer behaviors, overall spending capacity analysis, market expansion rate, etc. This study categorizes the global Cell Isolation Technology breakdown data by manufacturers, region, type, and applications, also analyzes the market drivers, opportunities, and challenges. There is a section featuring the essential data gathered through Industry specialists and key authorities of profiled organizations. Leading players are considered relying upon their organization profile, item portfolio, limit, item/benefit value, deals, and cost/benefit.

NOTE:This report takes into account the current and future impacts of COVID-19 on this industry and offers you an in-dept analysis of Cell Isolation Technology market.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketsandresearch.biz/sample-request/59723

Key manufacturers analysis: Thermo Fisher Scientific, Inc., Merck, Beckman Coulter, Inc., Terumo BCT, BD Biosciences, Bio-Rad Laboratories, Inc., GE Healthcare, Stemcell Technologies,

On the basis of product types, the global market is classified into: Centrifugation, Flow Cytometry, Cell Electrophoresis,

On the basis of end-users, the global market is classified into: Stem cell research, Cancer research, Tissue regeneration, In-vitro diagnostics, Other

This Report Enfolds Following Market Aspects:

Key players strategic initiatives and competitive developments such as joint ventures, mergers, and new product launches in the market are taken into consideration. Cell Isolation Technology providers, research and consulting firms, government and research organizations, and associations and industry bodies are the target audiences of this market research report. Forecast estimates are given for regional demand & supply factor, investment, market dynamics including technical scenario, consumer behavior, and end-use industry trends and dynamics, and capacity.

The global Cell Isolation Technology market report also analyzes the major geographic regions as well as the major countries in these regions. The regions and countries covered in the study include: Americas (United States, Canada, Mexico, Brazil), APAC (China, Japan, Korea, Southeast Asia, India, Australia), Europe (Germany, France, UK, Italy, Russia), Middle East & Africa (Egypt, South Africa, Israel, Turkey, GCC Countries)

ACCESS FULL REPORT: https://www.marketsandresearch.biz/report/59723/global-cell-isolation-technology-market-growth-status-and-outlook-2020-2025

Report Answers Following Questions:

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Marketsandresearch.biz is a leading global Market Research agency providing expert research solutions, trusted by the best. We understand the importance of knowing what global consumers watch and buy, further using the same to document our distinguished research reports. Marketsandresearch.biz has worldwide presence to facilitate real market intelligence using latest methodology, best-in-class research techniques and cost-effective measures for worlds leading research professionals and agencies. We study consumers in more than 100 countries to give you the most complete view of trends and habits worldwide. Marketsandresearch.biz is a leading provider of Full-Service Research, Global Project Management, Market Research Operations and Online Panel Services.

Contact UsMark StoneHead of Business DevelopmentPhone:+1-201-465-4211Email:[emailprotected]Web:www.marketsandresearch.biz

Visit link:
Global Cell Isolation Technology Market 2020 Competition Landscape and Growth Opportunity, Industry Status and Forecast 2025 - Jewish Life News

Cell Isolation Technology Market By Covid-19 Impact Analysis Volume and Value, Revenue, Business Opportunity, Future Projections, and Key Trends -…

The research study Cell Isolation Technology market 2020 launched by ABRReports.com provides the detailed analysis of the current market status, investment plans, production and consumption, price trends, and analysis by the market player, by region, by type, by application and etc, and custom research can be added according to specific requirements

Get Sample Copy of the report at https://www.abrreports.com/industry-insights/covid-19-impact-on-2020-2026-global-and-regional-cell-isolation-technology-industry-production-sales-and-consumption-status-and-prospects-professional-market-research-report-standard-version?form=request-report-sample

The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 50 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth.

The key players covered in the Cell Isolation Technology Market research report are:By Market Players:Thermo Fisher Scientific, Inc.Bio-Rad Laboratories, Inc.Beckman Coulter, Inc.MerckStemcell TechnologiesBD BiosciencesGE HealthcareTerumo BCT

By TypeCentrifugationFlow CytometryCell Electrophoresis

By ApplicationStem cell researchCancer researchTissue regenerationIn-vitro diagnosticsOthers

Click to access full report and Table of Content at https://www.abrreports.com/industry-insights/covid-19-impact-on-2020-2026-global-and-regional-cell-isolation-technology-industry-production-sales-and-consumption-status-and-prospects-professional-market-research-report-standard-version

The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.

Key pointers of the Table of Contents:

Chapter 1 Industry OverviewChapter 2 Global Cell Isolation Technology Competition by Types, Applications, and Top Regions and CountriesChapter 3 Production Market AnalysisChapter 4 Global Cell Isolation Technology Sales, Consumption, Export, Import by Regions (2015-2020)Chapter 5 North America Cell Isolation Technology Market AnalysisChapter 6 East Asia Cell Isolation Technology Market AnalysisChapter 7 Europe Cell Isolation Technology Market AnalysisChapter 8 South Asia Cell Isolation Technology Market AnalysisChapter 9 Southeast Asia Cell Isolation Technology Market AnalysisChapter 10 Middle East Cell Isolation Technology Market AnalysisChapter 11 Africa Cell Isolation Technology Market AnalysisChapter 12 Oceania Cell Isolation Technology Market AnalysisChapter 13 South America Cell Isolation Technology Market AnalysisChapter 14 Company Profiles and Key Figures in Cell Isolation Technology BusinessChapter 15 Global Cell Isolation Technology Market Forecast (2021-2026)Chapter 16 Conclusions

Purchase the research study @

https://www.abrreports.com/industry-insights/covid-19-impact-on-2020-2026-global-and-regional-cell-isolation-technology-industry-production-sales-and-consumption-status-and-prospects-professional-market-research-report-standard-version/checkout?option=one

About Us:

ABR Reports (Advanced Business Research Reports) is the premium market research reselling company that offers market research reports to individuals, organizations, and industries to enhance and strengthen the decision making process. With an associate thoroughgoing list of market research Publishers, we tend to cut across all the business verticals covering 5000+ micro markets and offer market size and share analysis, industry trends, information on products, regional market, and keen business insights to our clients.

Contact Us:

Scott HarrisSales ManagerEmail ID: [emailprotected]Phone No.: +1-561-448-7424

Read more:
Cell Isolation Technology Market By Covid-19 Impact Analysis Volume and Value, Revenue, Business Opportunity, Future Projections, and Key Trends -...

Global 3D Cell Culture Market is Booming Across the Globe Explored in Latest Report 2020 2027 | Top Key players Analysis by Thermo Fisher, Corning,…

3D cell culture is an artificially-created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Unlike 2D environments (e.g. a petri dish), a 3D cell culture allows cells in vitro to grow in all directions, similar to how they would in vivo. These three-dimensional cultures are usually grown in bioreactors, small capsules in which the cells can grow into spheroids, or 3D cell colonies. Approximately 300 spheroids are usually cultured per bioreactor. The 3D Cell Culture Market is expected to reach +20% CAGR during forecast period 2020-2027

Request anExclusive Sample Copy of This 3D Cell Culture Marketreport at

https://www.marketresearchinc.com/request-sample.php?id=30589

According to the research report, the global 3D Cell Culture Market has gained significant momentum over the recent past. The increasing acceptance, the rising demand and the growing need for this markets products are mentioned in the study. The factors fueling their adoption among consumers are mentioned in this report study. This market report offers a comprehensive analysis of the overall scenario in the global market. It evaluates this market taking a number of important parameters, such as the type and application, into consideration. The geographical presence of the market has also been examined closely in this research study.

Key Players in this 3D Cell Culture Market are: Thermo Fisher (US), Corning (US), Lonza (Switzerland), Merck (Germany), ReproCELL (Japan), and InSphero (Switzerland). The other players operating in this market include Global Cell Solutions (US), Synthecon (US), 3D Biotek (US), Kuraray (Japan), Hamilton Company (US), Mimetas (Netherlands), Emulate (US), Nano3D Biosciences (US), and QGel (Switzerland).

Available Discount on this report at

https://www.marketresearchinc.com/ask-for-discount.php?id=30589

On the basis of geography, the global market for agricultural enzymes has been categorized into Europe, Asia-Pacific, North America, Middle East & Africa and Latin America. The leading region of the global market is further mentioned along with the reason behind its growth. Every region key factor is provided which is attracting this market towards growth. The report also elaborates on the opportunities the emerging markets of Asia Pacific and Latin America offer. The research report also analyzes the market hierarchy carrying out a SWOT analysis of the key players operating in the global 3D Cell Culture market.

Key points of 3D Cell Culture Market Report

3D Cell Culture Market Segment by Type,

Market Segment by Applications, can be divided into

Inquire for further detailed information 3D Cell Culture Market Report at

https://www.marketresearchinc.com/enquiry-before-buying.php?id=30589

In this study, the years considered to estimate the size of 3D Cell Culture are as follows:

History Year: 2013-2018

Base Year: 2018

Estimated Year: 2019

Forecast Year 2019 to 2025.

About Us

Market Research Inc is farsighted in its view and covers massive ground in global research. Local or global, we keep a close check on both markets. Trends and concurrent assessments sometimes overlap and influence the other. When we say market intelligence, we mean a deep and well-informed insight into your products, market, marketing, competitors, and customers. Market research companies are leading the way in nurturing global thought leadership. We help your product/service become the best they can with our informed approach.

Contact:

Market Research Inc

Kevin

51 Yerba Buena Lane, Ground Suite,

Inner Sunset San Francisco, CA 94103, USA

Call Us:+1 (628) 225-1818

Write [emailprotected][emailprotected]

Excerpt from:
Global 3D Cell Culture Market is Booming Across the Globe Explored in Latest Report 2020 2027 | Top Key players Analysis by Thermo Fisher, Corning,...

This startup aims to empower 1 million parents in guiding their childrens career choices – YourStory

Lifology has certainly been creating a buzz in career guidance space since its inception in 2018. The Uttar Pradesh government has partnered with the startup in providing digital career guidance at schools across the state. Lifology has also partnered with the Adani Foundation to support children in the coastal region of Kerala in career selection and even GEMS Education, the worlds largest K-12 education provider, has secured Lifology as a permanent partner in providing career assessment and coaching for their students across more than 40 countries.

Lifologys work speaks for itself. Two research reports on parenting that were written by this fast-growing organisation got featured in leading media houses in the country. They recently raised $1 million in funding from a team of investors in the UAE to further develop their Artificial Intelligence (AI) algorithms.

On June 1, the Global Day of Parents as declared by the United Nations, Lifology has launched its novel platform, the Super Parent Eco-system.

To know more about the genesis, the vision, and the functioning of the Super Parent Eco-system, YourStory spoke Praveen Parameswar, CEO of Lifology. Praveen is an alumnus of the London School of Economics and the University of Cardiff, UK. He has 10 years of experience in working as an organisation development consultant, trainer and leadership coach in the UK, India and across the Middle East. He is the author of Thinking Beyond the Paradigms and a well acclaimed TEDx speaker.

Praveen Parameswar

YourStory (YS): What inspired Lifology to launch Super Parent Eco-system?

Praveen Parameswar (PP): We want to make this world a better place where people enjoy more happiness, fulfilment, financial security and purpose.

The 21st century has been unfolding with incredible developments. AI, Robotics, Genome Research, Stem Cell research, Virtual Reality, Augmented Reality, developments in longevity studies and other innovations will phenomenally change the way we live. And in recent months, Covid-19 has is in fact been acting as a catalyst to the development of these innovations. Under the influence of these massive developments, our systems of education, our expectations around employment, and even the career landscape, will undergo rapid transformations.

In this chaotic scenario, our children require strong support to make the right choices around their higher education and career. More than 76 percent of children consider their parents to be the most important influencer in choosing higher education and career, but majority of their parents do not feel capable to do this effectively.

The Super Parent Eco-system is on a mission to empower every parent in India to lead their child to the most appropriate career where they enjoy happiness, fulfilment, financial security and purpose.

YS: How does Lifology plan to achieve this ambitious mission?

PP: Lifologys Super Parents Eco-system is a combination of five elements: Lifology Magazine, Lifology TV, Lifology Hub, Lifology Connect and most importantly the Lifology Super Parent Community.

The complete system, powered by Artificial Intelligence and Augmented Reality, will give parents access to carefully curated information on new age career options, provide a tool kit to map children to the most appropriate career pathways and connect them to a network of career coaches that rank among worlds top 80th percentile. Regular, exclusive live sessions on career selection and education, and cutting-edge programs for life skills development, among a myriad of other features, will empower the decision-making skills of our Super Parents even further.

YS: Why are you focusing only on parents? What about schools, governments, educational institutions and other stakeholders involved in the process of a childs career decision?

PP: As I mentioned earlier, the Super Parent Eco-system is the newest venture by Lifology. We are giving ultra-focus on this vertical because parents play a major role in the education and career decision making of their children. Thus, we believe that paying more attention in this area will help us to move faster towards our vision.

However, along with this, we closely work with various state governments and school chains across India, UK, UAE, Qatar, Kuwait, Bahrain, Egypt, Saudi Arabia and Singapore.

YS: What are the major challenges you see on your way forward?

PP: The tendency of many to base decisions on limited information they have at any point in time would be the major challenge we expect to face on our path. The stubbornness that comes naturally comes from an ego-centric perspective, which says its my childs decision, who are you to counsel me on this?, is another roadblock we face. In addition, the time, energy and patience that parents can spare for this initiative towards constructive development is also quite critical.

Q: What is Lifologys key strength?

We are motivated by our Mission.

We see meaning, purpose and a compelling Why in what we do. The success of our mission would make our community, and subsequently the entire world, a great place to live in. This makes us put our heart and soul into what we do.

We have an extraordinary team comprising of alumni of the Harvard University, IIM Ahmedabad, IIM Kozhikode, Oxford University and the various IITs. Our Chief Assessment Officer, Dr Marilyn Maze, carries an experience of four decades in the arena of career guidance. My Co-founder, Rahul Nair, is the only representative of India in the Asia Pacific Career Development Associations Executive Council. This team pushes our vision further.

YS: Does Covid-19 affect your business?

PP: Actually, we see the scenario created by the current pandemic in a positive light. Lifology is a 100 percent digital platform. Traditionally, there has been a lot of reluctance from parents to follow digital solutions for education and career decisions. But over the last three months, we have witnessed many drastic changes in Indian parents mindset towards e-learning and guidance, which otherwise would have taken over a decade.

YS: What are your future plans?

PP: We are on a mission to support at least 1 million parents in next 24 months. Our vision is to expand Lifologys services to every state, district and village in India and launch in local languages also. We strive to bring global knowledge to every part of India and empower Indian parents to be the worlds best Super Parent community.

Want to make your startup journey smooth? YS Education brings a comprehensive Funding and Startup Course. Learn from India's top investors and entrepreneurs. Click here to know more.

Originally posted here:
This startup aims to empower 1 million parents in guiding their childrens career choices - YourStory

Advanced Cell Therapies Market 2020-2026: Analysis by Growth Factors, Key Trends and Competitive Strategies – Cole of Duty

The research study Advanced Cell Therapies market 2020 launched by ABRReports.com provides the detailed analysis of the current market status, investment plans, production and consumption, price trends, and analysis by the market player, by region, by type, by application and etc, and custom research can be added according to specific requirements

Get Sample Copy of the report at https://www.abrreports.com/industry-insights/covid-19-impact-on-2020-2026-global-and-regional-advanced-cell-therapies-industry-production-sales-and-consumption-status-and-prospects-professional-market-research-report-standard-version?form=request-report-sample

The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 50 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth.

The key players covered in the Advanced Cell Therapies Market research report are:By Market Players:FRC Blood ServiceOkyanosAdvanced Cell Technology, IncFujifilmGamida CellVericelBioXcelleratorKolon TissueGeneLocate Bio LimitedRexgeneroTakuraAutolus

By TypeStem Cell TransplantsCAR T-cell Therapy

By ApplicationStem CellRegenerative Medicine

Click to access full report and Table of Content at https://www.abrreports.com/industry-insights/covid-19-impact-on-2020-2026-global-and-regional-advanced-cell-therapies-industry-production-sales-and-consumption-status-and-prospects-professional-market-research-report-standard-version

The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.

Key pointers of the Table of Contents:

Chapter 1 Industry OverviewChapter 2 Global Advanced Cell Therapies Competition by Types, Applications, and Top Regions and CountriesChapter 3 Production Market AnalysisChapter 4 Global Advanced Cell Therapies Sales, Consumption, Export, Import by Regions (2015-2020)Chapter 5 North America Advanced Cell Therapies Market AnalysisChapter 6 East Asia Advanced Cell Therapies Market AnalysisChapter 7 Europe Advanced Cell Therapies Market AnalysisChapter 8 South Asia Advanced Cell Therapies Market AnalysisChapter 9 Southeast Asia Advanced Cell Therapies Market AnalysisChapter 10 Middle East Advanced Cell Therapies Market AnalysisChapter 11 Africa Advanced Cell Therapies Market AnalysisChapter 12 Oceania Advanced Cell Therapies Market AnalysisChapter 13 South America Advanced Cell Therapies Market AnalysisChapter 14 Company Profiles and Key Figures in Advanced Cell Therapies BusinessChapter 15 Global Advanced Cell Therapies Market Forecast (2021-2026)Chapter 16 Conclusions

Purchase the research study @

https://www.abrreports.com/industry-insights/covid-19-impact-on-2020-2026-global-and-regional-advanced-cell-therapies-industry-production-sales-and-consumption-status-and-prospects-professional-market-research-report-standard-version/checkout?option=one

About Us:

ABR Reports (Advanced Business Research Reports) is the premium market research reselling company that offers market research reports to individuals, organizations, and industries to enhance and strengthen the decision making process. With an associate thoroughgoing list of market research Publishers, we tend to cut across all the business verticals covering 5000+ micro markets and offer market size and share analysis, industry trends, information on products, regional market, and keen business insights to our clients.

Contact Us:

Scott HarrisSales ManagerEmail ID: [emailprotected]Phone No.: +1-561-448-7424

More:
Advanced Cell Therapies Market 2020-2026: Analysis by Growth Factors, Key Trends and Competitive Strategies - Cole of Duty

Biotechs Working on COVID 19 – TheBull.com.au

14 June 2020 9min read

On 11 June Aussie investors got a wake-up call from the chairman of the US Federal Reserve, Jerome Powell, sending the ASX 200 plunging 3%, its worst close in six weeks. US markets followed suit, dropping 4.25% by midday on the 11th and closing down 6.9%, dropping 1,861 points. However, although the ASX closed the week lower down 1.89% the buyers returned to US markets on the last day of trading there, sending the Dow Jones Industrial Average up by 1.95%.

With countries all over the world getting back to business and concerns about the spread of COVID-19 fading from the public consciousness in general and investor consciousness in particular, global share markets remained confident in anticipation of a quick v-shaped recovery.

Powell threw water on that argument, in the official statement released by the Fed:

Skeptical investors may have noticed the tendency of market participants to accentuate whatever bits of positive news comes out, often ignoring negative undertows. Reaction to this announcement reversed the trend, grabbing on to the phrases in the statement ongoing public health crisis and medium term economic outlook despite statements the US economy would recover eventually.

The Chairman clearly linked the economic recovery to the coronavirus, citing issues like the length of time for treatments and a virus as well as rises in the number of infected as social distancing practices fall by the wayside.

The key point investors need to bring into focus is that despite declining cases in most countries and the accompanying willingness of the public to ignore warnings, COVID-19 has not gone away, even here in Australia.

While the numbers by state might be cause for optimism in most of the country, the push for a full reopening of Australian businesses and the easing of travel restrictions suggest at the very least the possibility of increasing cases here.

In the US 16 states are seeing increases in COVID-19 cases in the double digits, raising the alarm among some in that country that the dreaded second wave is soon at hand.

With COVID-19 still very a factor looming over economic recoveries everywhere, biotech stocks involved in any way in the search for a vaccine or treatments for the virus could prosper in the medium term if successful.

The ASX has one of its flagship stocks, CSL Limited (CSL) in a position to increase its already stellar reputation through its partnership role in the CoVIg-19 Plasma Alliance, comprised of leading experts from the industry. In addition, CSL is developing COVID-19 Immunoglobulin, a plasma product with the potential to treat people in the Australian market with respiratory complications due to COVID-19.

There are a number of small cap biotechs that merit attention, along with long time large cap heart breakers Mesoblast Limited (MSB). The following table lists them by market cap, along with price information.

Four of these stocks have turned in stellar year over year share price appreciation for their investors.

Mesoblast is involved in regenerative medicine with its three proprietary technologies Mesenchymal Precursor Cells (MPCs), culture-expanded Mesenchymal Stem Cells (MSCs), Dental Pulp Stem Cells (DPSCs) and expanded Hematopoietic Stem Cells (HSCs).

These technology platforms address complex medical issues involving inflammation and damaged tissue. The company has five treatments in various stages of clinical trials, with one Ryoncil approaching registration status with a launch in the US on the horizon. Ryoncil, or Remestemcel-L, treats inflammatory conditions of the kind associated with COVID-19 acute respiratory distress stress syndrome (ARDS). After a successful pilot trial the US FDA (Food and Drug Administration) cleared Remestemcel-L for a randomized controlled Phase 3 Trial involving 300 patients in 30 different sites across the US. Confident of a successful trial, Mesoblast has already concluded a capital raise totaling $138 million dollars to go towards the eventual manufacture of the treatment.

Atomo Diagnostics (AT1) is virtually a newborn on the ASX, listing on 30 April of 2020 with a first day closing price of $0.48, declining steadily to reach the current $0.30 per share. The company entered the ASX with both a professional use rapid diagnostic test (RDT) and a self-testing device for the HIV virus. Atomo, working with French in vitro diagnostic specialist NG Biotech SAS, has developed an RDT platform for professionals to test for the presence of antibodies in response to COVID-19. NG Biotech has granted exclusive distribution rights to Atomo for Australia, New Zealand, and other South East Asian countries, following NGs purchase of 1.5 million tests for use in France.

Dimerix Limited (DXB) got a huge boost on 4 June when the stock price jumped 54% with the announcement its lead candidate to treat kidney disease DMX-200 had been selected to join a global study (REMAP-CAP) on treatments for COVID-19 induced ARDS. The study is funded by both government and non-government organisations with an endorsement from the WHO (World Health Organisation).

The company listed on the ASX in 2015 following a reverse merger. Dimerix has another DMX-200 treatment for kidney scarring in clinical trials and another DMX-700 for COPD (chronic obstructive pulmonary disease) starting pre-clinical studies.

Cynata Therapeutics (CYP) is developing a platform using Cymerus technology for manufacturing mesenchymal stem cells (MSCs) for therapeutic use. The technology could be disruptive in that it could allow manufacture of stem cells for therapeutic use in commercial scale quantities from a single donation of a single cell.

The company has completed successful preclinical studies targeting different diseases, including asthma, heart attack, sepsis, and cytokine release syndrome (an inflammatory condition with infections.) FUJIFILM Corporation has licensed the technology from Cynata to treat graft-versus-host disease in people following a successful Phase 1 clinical trial.

On 11 March of 2020, the company announced it was in active discussions with international pharmaceutical companies to use the Cymerus technology platform to treat COVID-19 patients with severe symptoms.

On 8 May Cynata announced approval to begin a clinical trial in Australia to determine the efficacy of its stem cells from its Cymerus technology platform to treat ICU (intensive care unit) COVID-19 patients.

Impression Healthcare (IHL) is a custom fit dental products company that got involved in medical marijuana, with clinical trials for the treatment of gingivitis and gum disease. On 1 May the company announced a preclinical animal study to test its cannabinoid drug IHL-675A for treating a leading cause of deaths from COVIOD-19 sepsis-related ARDS. The trial began on 2 June. On 3 June Impression announced it was abandoning its oral device business to focus on medical marijuana in anticipation of significantly higher revenue for the June Quarter for its existing Icannex branded cannabinoids.

PharmAust Limited (PAA) has a business model aimed at a newer approach to drug development repurposing drugs approved for other treatment conditions. In the past, discoveries that a given drug to treat condition X could also treat condition Y were accidental. PharmAusts lead drug Monepantel (MPL) is a cancer treatment that has successfully completed Phase 1 clinical trials for use in both humans and dogs. The treatment for dogs is starting Phase 2 trials. The company also has a portfolio of cancer treatments in preclinical stages.

On 4 June, the company announced it had expanded its portfolio enhancement efforts to include a preliminary study on the effects of Monepantel on COVID-19 patients. Following positive results potential suppression of the virus by up to 95% PharmAust filed a patent application for the use of Monepantel in COVID-19 cases. The share price went up 40% on the news.

In yet another example of an ASX small cap biotech discovering treatments developed for other purposes could help in treating COVID-19, Noxopharm Limited (NOX) announced on 1 April it too was ready to get into the race to find effective treatments.

The companys lead candidate is a late stage cancer treatment primarily targeting prostate cancer idronoxil with the brand name Veyonda. Examining their preclinical work on the drug, Noxopharm found idronoxil suppressed the cytokine molecules responsible for triggering inflammation of the type affecting the respiratory systems of COVID-19 patients.

On 21 April, the company announced it was applying for US FDA (food and drug administration) approval to conduct a clinical study for Veyonda.

All of the companies listed here are developing treatments that may fade away at some time in the unknown future. Interested investors should also consider the potential of the companys other offerings as even with success in the treatments developed, their revenue generating potential could be short-lived.

View original post here:
Biotechs Working on COVID 19 - TheBull.com.au

Houston coronavirus updates: What you need to know about June 14 – msnNOW

9:16 a.m.

Texas reported a record high of 2,242 COVID-19 hospitalizations on Saturday, according to Texas Health and Human Services.

Last week, Texas set a new record for COVID-19 hospitalizations in four of the five days, climbing to 2,166 on Friday.

Health officials are concerned that the increase may strain hospital capacity. Dr. James McCarthy, Chief Physician Executive of Memorial Hermann warned about the recent COVID-19 surge and hospital capacity.

"We need to protect hospital capacity for important healthcare needs," McCarthy said, "The one thing we don't want to see is where hospital capacity is strained in a way where the rest of the patients can't be cared for. Important surgeries still need to go on." Read more details of his interview here.

In an in-depth report by Houston Chronicle's Jenny Deam, Houston hospitals are now ramping up the number of beds and ventilators available. There are nearly 18,000 beds available statewide, an increase of about 4,700 from Thursday. Read more of her in-depth report here.

9:05 a.m.

As of Sunday morning, there are now 7,817,064 cases of the novel coronavirus worldwide, according to Johns Hopkins University. The death toll now has climbed to 430,605. The U.S. currently leads the world with 2,074,749 confirmed cases.

According to Texas Health and Human Services, there are now 86,011 cases reported across the state. Harris County leads the state, reporting 16,188 confirmed cases.

Read the original:
Houston coronavirus updates: What you need to know about June 14 - msnNOW